Process for listing high-cost medicines | Australia | England | South Korea |
---|---|---|---|
Responsible parties in each step for listing of high-cost medicines | |||
Submit the application | Sponsor* company submits a dossier after medicine is rejected by PBS | All novel cancer medicines submitted by sponsor | Application and related dossier submitted by sponsor company |
Review the evidence | LSDP expert panel | NICE appraisal committee | HIRA—BCA committee and EE sub-Committee |
Appraise the evidence | Chief Medical Officer (LSDP) | NICE advisory committee | PBC |
Time for appraisal | 2–6 weeks | 90 days | 120 days |
Price Negotiations | MoH and Sponsor | NHS and Sponsor | NHIS and Sponsor |
Final decision | MoH | NICE | MOHW |
Re-evaluation | MoH every 2Â years | NICE every 2Â years | MOHW every 2Â years |